The number of adults with cystic fibrosis (CF) is now higher than the number of pediatric patients. As life expectancy increases, patients are increasingly affected by comorbidities, particularly CF-related diabetes and mental disorders. These conditions worsen outcomes and disproportionately affect ethnic minorities due to the underlying social determinants of health ( SDOH).
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- Ischemic stroke: Are smaller or larger brain arteries affected?
Recent study findings on intravenous lysis therapy with fibrinolytic agents
- Interview
“On par with the gold standards for trauma”
- Psychology: Emotional Freedom Techniques (EFT)
Emotional Healing Through Tapping
- Systemic Lupus (SLE): What Does the Diagnosis and Treatment Toolbox Have to Offer?
Treat-to-Target – Consensus Recommendations for GC Tapering and the Use of DMARDs
- Psychedelic-assisted therapy
Current status of PAT
- Interstitial Lung Diseases
Update on Idiopathic Pulmonary Fibrosis
- Psoriasis and Obesity: Effects of Incretin-Based Therapies
Clinical trials shed light on the potential of semaglutide, liraglutide, and tirzepatide
- Non-small-cell lung cancer (NSCLC)